DEXCOM, INC. Payments to Acquire Other Investments
DEXCOM, INC. (DXCM) reported Payments to Acquire Other Investments of $1.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2026-07-30
- DEXCOM, INC. payments to acquire other investments for the quarter ending 2026-06-30 was $0.00.
- DEXCOM, INC. payments to acquire other investments for the quarter ending 2026-03-31 was $1.50M.
- DEXCOM, INC. payments to acquire other investments for the quarter ending 2025-12-31 was $1.20M, a 98.40% decline year-over-year.
- DEXCOM, INC. payments to acquire other investments for the quarter ending 2025-09-30 was $18.00M.
- DEXCOM, INC. payments to acquire other investments for fiscal 2025 was $19.20M, a 76.38% decline from fiscal 2024.
- DEXCOM, INC. payments to acquire other investments for fiscal 2024 was $81.30M, a 316.92% increase from fiscal 2023.
- DEXCOM, INC. payments to acquire other investments for fiscal 2023 was $19.50M, a 34.48% increase from fiscal 2022.
- DEXCOM, INC. payments to acquire other investments for fiscal 2022 was $14.50M.
| Period end | Payments to Acquire Other Investments 3 month | Payments to Acquire Other Investments 6 month | Payments to Acquire Other Investments 9 month | Payments to Acquire Other Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.50M 10-Q · filed 2026-07-30 | $2.70M derived: sum of 3 quarters · filed 2026-07-30 | $20.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $1.50M 10-Q · filed 2026-04-30 | $2.70M derived: sum of 2 quarters · filed 2026-04-30 | $20.70M derived: sum of 3 quarters · filed 2026-04-30 | $20.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $19.20M derived: sum of 2 quarters · filed 2026-02-12 | $19.20M derived: sum of 3 quarters · filed 2026-07-30 | $19.20M 10-K · filed 2026-02-12 |
| 2025-09-30 | $18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $18.00M derived: sum of 2 quarters · filed 2026-07-30 | $18.00M 10-Q · filed 2025-10-30 | $93.10M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | $75.10M derived: sum of 3 quarters · filed 2026-07-30 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | $75.10M derived: sum of 2 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $75.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $81.30M 10-K · filed 2026-02-12 | ||
| 2024-09-30 | $6.20M 10-Q · filed 2025-10-30 | |||
| 2023-12-31 | $19.50M 10-K · filed 2026-02-12 | |||
| 2022-12-31 | $14.50M 10-K · filed 2025-02-18 | |||
| 2020-03-31 | $0.00 10-Q · filed 2020-04-28 | $0.00 derived: sum of 2 quarters · filed 2020-04-28 | $0.00 derived: sum of 3 quarters · filed 2020-04-28 | $0.00 derived: sum of 4 quarters · filed 2020-04-28 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $0.00 derived: sum of 3 quarters · filed 2020-02-13 | $1.20M 10-K · filed 2020-02-13 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $1.20M 10-Q · filed 2019-11-06 | $1.20M derived: sum of 4 quarters · filed 2020-04-28 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $1.20M 10-Q · filed 2019-07-31 | $1.20M derived: sum of 3 quarters · filed 2020-04-28 | $1.20M derived: sum of 4 quarters · filed 2020-04-28 |
| 2019-03-31 | $1.20M 10-Q · filed 2020-04-28 | $1.20M derived: sum of 2 quarters · filed 2020-04-28 | $1.20M derived: sum of 3 quarters · filed 2020-04-28 | $1.20M derived: sum of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $0.00 derived: sum of 3 quarters · filed 2020-02-13 | $1.00M 10-K · filed 2020-02-13 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $1.00M 10-Q · filed 2019-11-06 | $1.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $1.00M 10-Q · filed 2019-07-31 | $1.00M derived: sum of 3 quarters · filed 2020-02-13 | $1.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-01 | $1.00M derived: sum of 2 quarters · filed 2020-02-13 | $1.00M derived: sum of 3 quarters · filed 2020-02-13 | $1.00M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $0.00 derived: sum of 3 quarters · filed 2020-02-13 | $0.00 10-K · filed 2020-02-13 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $0.00 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-02 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |